Hormones for suspected impaired fetal growth.

G J Hofmeyr, A M Gulmezoglu, L Say

Journal: The Cochrane database of systematic reviews 2003

PMID: 12535384

Abstract

BACKGROUND

It has been suggested that oestrogens may improve fetal growth due to an increase in nutritional supply to the fetus from greater uterine blood flow.

OBJECTIVES

The objective of this review was to assess the effects of hormone administration for suspected impaired fetal growth and perinatal outcome.

SEARCH STRATEGY

We searched the Cochrane Pregnancy and Childbirth Group trials register (1 November 2002).

SELECTION CRITERIA

Acceptably controlled trials of hormone administration for suspected impaired fetal growth which report fetal, perinatal or maternal outcomes.

DATA COLLECTION AND ANALYSIS

Eligibility and trial quality were assessed.

MAIN RESULTS

No studies were included since none of the potentially relevant trials reported clinical outcomes.

REVIEWER'S CONCLUSIONS

There is not enough evidence to evaluate the clinical use of hormone administration for suspected impaired fetal growth.

Address: Department of Reproductive Health and Research, World Health Organization, 20 Avenue Appia, Geneva 27, Switzerland. [email protected]

Link outs

Subscription / membership required

Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.